Pages that link to "Q71373474"
Jump to navigation
Jump to search
The following pages link to 3H-apomorphine labels both dopamine postsynaptic receptors and autoreceptors (Q71373474):
Displaying 31 items.
- Metric Validation and the Receptor-Relevant Subspace Concept (Q28842828) (← links)
- Pharmacological effects of Ro 22-1319: A new antipsychotic agent (Q34247375) (← links)
- Localization of D1 and D2 dopamine receptors in brain with subtype-specific antibodies (Q36558137) (← links)
- Presynaptic regulation of neurotransmitter release in the brain: Facts and hypothesis (Q40094853) (← links)
- Dopamine receptors in the central nervous system. (Q40243147) (← links)
- Dopaminergic phenotype of hNT cells in vitro (Q40865541) (← links)
- Unilateral 6-hydroxydopamine lesions of meso-striatal dopamine neurons and their physiological sequelae (Q41173089) (← links)
- Selection of dopamine antagonists discriminating various behavioral responses and radioligand binding sites (Q41535903) (← links)
- Dopaminergic D-3 binding sites are not presynaptic autoreceptors (Q42248753) (← links)
- Apomorphine effects on brain metabolism in neuroleptic-naive schizophrenic patients (Q44536244) (← links)
- Note on an abnormality of the operator for the structural gene of the dopamine D1 receptor as a possible partial cause of schizophrenia (Q44656895) (← links)
- Autoradiographic localisation of 3H-apomorphine binding sites in rat brain (Q48476615) (← links)
- Apomorphine anorexia: a behavioural and neuropharmacological analysis (Q48559791) (← links)
- An improved differential pulse voltammetry technique allows the simultaneous analysis of dopaminergic and serotonergic activities in vivo with a single carbon-fibre electrode (Q48600946) (← links)
- Interaction of the component enantiomers of the putative dopamine autoreceptor agonist, TL-99 (6,7-dihydroxy-2-dimethylamino tetralin) with dopaminergic systems in mammalian brain and teleost retina. (Q48712921) (← links)
- Dopamine receptor changes in untreated and ( )-PHNO-treated MPTP parkinsonian primates (Q48723014) (← links)
- Adaptive Changes of Neurotransmitter Receptor Mechanisms in the Central Nervous System (Q48855237) (← links)
- Neurochemical Studies of the Mesolimbic Dopaminergic Pathway: [3H]Spiperone Labels Two Binding Sites in Homogenates of the Nucleus Accumbens of Rat Brain (Q48882530) (← links)
- Guanine nucleotides do not inhibit tritiated dopamine agonist binding to bovine striatal membranes (Q48924391) (← links)
- Possible mechanism of prolactin unresponsiveness to repeated sulpiride administration in man. (Q54483331) (← links)
- Alternative splicing directs the expression of two D2 dopamine receptor isoforms. (Q55058608) (← links)
- Schizophrenia: synthetic strategies and recent advances in drug design (Q57393544) (← links)
- Prolactin unresponsiveness to repeated sulpiride administration in man: recent findings (Q70341722) (← links)
- Three classes of dopamine receptor (D-2, D-3, D-4) identified by binding studies with 3H-apomorphine and 3H-domperidone (Q70702293) (← links)
- Effect of a stereospecific D2-dopamine agonist on acetylcholine concentration in corpus striatum of rat brain (Q71147343) (← links)
- Dopaminergic binding sites in rat striatal slices and the action of guanyl nucleotides (Q71333671) (← links)
- Adaptive changes in catecholamine receptors in the central nervous system (Q72490144) (← links)
- Pharmacological characterization of the receptors involved in the apomorphine-induced polyphasic modifications of locomotor activity in mice (Q72565508) (← links)
- Action of apomorphine, bromocriptine and lergotrile on gamma-aminobutyric acid and acetylcholine release in nucleus accumbens and corpus striatum (Q72571345) (← links)
- The Dopamine/Neuroleptic Receptor (Q72812004) (← links)
- Improved electron-conformational method of pharmacophore identification and bioactivity prediction. Application to angiotensin converting enzyme inhibitors (Q73323020) (← links)